NAUT
Nautilus Biotechnology
$0.99
−$0.13 (−11.61%)Sep 10, 2026
Key metrics
The numbers that frame NAUT today
- Market cap
- $125.98M
- P/E (TTM)
- -2.2
- EV / FCF
- -2.7
- Gross margin
- 92.1%
- EV / Sales
- 740.2
- ROIC
- -30.2%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $0.68
- 52wk High
- $4.31
Growth
Revenue and earnings trend for NAUT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NAUT
Is Nautilus Biotechnology a good buy?
No. Nautilus Biotechnology has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks strong, which supports the long-term business case, but that is not enough to offset the weak setup. We think Nautilus Biotechnology is selling at a very high price.
What is the market capitalization of NAUT?
Nautilus Biotechnology's market capitalization is $125.98M.
What is the P/E ratio for NAUT stock?
Nautilus Biotechnology's current P/E ratio is -2.2.
What is the 52-week high for NAUT stock?
The 52-week high for Nautilus Biotechnology is $4.31. The current close of $0.99 is 77% below that high.
What is the 52-week low for NAUT stock?
The 52-week low for Nautilus Biotechnology is $0.68. The current close of $0.99 is 45.4% above that low.
Does NAUT stock pay dividends?
Nautilus Biotechnology does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NAUT?
Nautilus Biotechnology's Debt / Equity ratio is 0.21.